OvaScience Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
OvaScience (OVAS) PT Trimmed at Wedbush
May 12, 2015 10:43 AM EDTWedbush analyst Zarak Khurshid trimmed his price target on OvaScience (NASDAQ: OVAS) to $52.00 (from $57.00) following Q1 revenues that was a little below the firm's and the Street consensus, but maintained an Outperform rating.
Khurshid commented, "Difficult to draw meaningful volume... More
